Literature DB >> 17103293

Survival of patients with colorectal cancer in Austria by sex, age, and stage.

Gerald Haidinger1, Thomas Waldhoer, Monika Hackl, Christian Vutuc.   

Abstract

This paper for the first time presents Austrian data on survival of patients, diagnosed from 1998 through 2002, with colon cancer and with rectal cancer. Cumulative relative survival rates were calculated by age, standardized for all ages and stages combined, and by age groups (< 50 years, 50-64 years, and =65 years) according to stages (localized, regional metastases and distant metastases). In carcinoma of the colon 5-year relative survival was 66 % in males and 64 % in females. In carcinoma of the rectum 5-year relative survival was 64 % in males and 67 % in females. Compared to the earlier results from the Tyrol (based on patients diagnosed from 1990 through 1994) the 5-year survival of patients with colon cancer increased from 55 % to 66 % in males and from 58 % to 64 % in females. In patients with rectal cancer 5-year survival increased from 44 % to 64 % in males and from 46 % to 67 % in females. This increase in part can be explained by a positive effect of early detection and of better treatment.

Entities:  

Mesh:

Year:  2006        PMID: 17103293     DOI: 10.1007/s10354-006-0339-9

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  8 in total

1.  Regression models for relative survival.

Authors:  Paul W Dickman; Andy Sloggett; Michael Hills; Timo Hakulinen
Journal:  Stat Med       Date:  2004-01-15       Impact factor: 2.373

Review 2.  [Recommendations on the diagnosis and multimodal primary therapy of rectal carcinomas 2004].

Authors: 
Journal:  Wien Klin Wochenschr       Date:  2005-02       Impact factor: 1.704

3.  Improvement in colorectal cancer survival: a population-based study.

Authors:  Emmanuel Mitry; Anne-Marie Bouvier; Jacques Esteve; Jean Faivre
Journal:  Eur J Cancer       Date:  2005-09-01       Impact factor: 9.162

Review 4.  [Drug therapy of colorectal carcinoma].

Authors:  Herbert Ulrich-Pur; Barbara Jech; Werner Scheithauer; Gabriela Verena Kornek; Heinz Huber
Journal:  Wien Klin Wochenschr       Date:  2002-06-14       Impact factor: 1.704

5.  Stage-specific survival of epithelial cancers in North-Holland/Flevoland, The Netherlands.

Authors:  O Visser; F E van Leeuwen
Journal:  Eur J Cancer       Date:  2005-08-26       Impact factor: 9.162

6.  Cancer mortality in Austria: 1970-2002.

Authors:  Christian Vutuc; Thomas Waldhoer; Gerald Haidinger
Journal:  Wien Klin Wochenschr       Date:  2004-10-30       Impact factor: 1.704

7.  EUROCARE-3: survival of cancer patients diagnosed 1990-94--results and commentary.

Authors:  M Sant; T Aareleid; F Berrino; M Bielska Lasota; P M Carli; J Faivre; P Grosclaude; G Hédelin; T Matsuda; H Møller; T Möller; A Verdecchia; R Capocaccia; G Gatta; A Micheli; M Santaquilani; P Roazzi; D Lisi
Journal:  Ann Oncol       Date:  2003       Impact factor: 32.976

8.  [Repeat mass screening for fecal occult blood for the diagnosis of colorectal neoplasms in a rural district. Results of an informational campaign].

Authors:  F Hofbauer; K Mach; G Egermann
Journal:  Wien Klin Wochenschr       Date:  1991       Impact factor: 1.704

  8 in total
  3 in total

1.  Case report: impressive response to pembrolizumab in a patient with mismatch-repair deficient metastasized colorectal cancer and bulky disease.

Authors:  Markus Kieler; Werner Scheithauer; Christoph C Zielinski; Andreas Chott; Ali Al-Mukhtar; Gerald W Prager
Journal:  ESMO Open       Date:  2016-12-15

2.  Evaluation of prognostic factors effect on survival time in patients with colorectal cancer, based on Weibull Competing-Risks Model.

Authors:  Soraya Moamer; Ahmadreza Baghestani; Mohamad Amin Pourhoseingholi; Nastaran Hajizadeh; Farzaneh Ahmadi; Mohsen Norouzinia
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2017

3.  Does the prognosis of colorectal cancer vary with tumor site?

Authors:  Mohamad Asghari Jafarabadi; Seyede Momeneh Mohammadi; Ebrahim Hajizadeh; Anoshirvan Kazemnejad; Seyed Reza Fatemi
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2011
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.